Is the treatment of hepatocellular carcinoma on the waiting list necessary?

Authors


  • This review is an improved version of a previous work that served as a syllabus for the 2010 transplant course of the American Association for the Study of Liver Diseases. That work was written with Christian Toso and Gilles Mentha (the Geneva group), whose intellectual contributions are gratefully acknowledged.

  • Potential conflict of interest: Nothing to report.

Ancillary